.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Deloitte
Healthtrust
Fish and Richardson
Federal Trade Commission
Covington
Dow
UBS
Fuji
Chinese Patent Office

Generated: December 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 204141

« Back to Dashboard

NDA 204141 describes TOPICORT, which is a drug marketed by Taro and is included in ten NDAs. It is available from three suppliers. There are three patents protecting this drug and one Paragraph IV challenge. Additional details are available on the TOPICORT profile page.

The generic ingredient in TOPICORT is desoximetasone. There are seven drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the desoximetasone profile page.

Summary for 204141

Tradename:1
Applicant:1
Ingredient:1
Patents:3
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)

Pharmacology for NDA: 204141

Medical Subject Heading (MeSH) Categories for 204141

Suppliers and Packaging for NDA: 204141

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TOPICORT desoximetasone SPRAY;TOPICAL 204141 NDA Taro Pharmaceuticals U.S.A., Inc. 51672-5281 51672-5281-0 1 BOTTLE in 1 CARTON (51672-5281-0) > 6 mL in 1 BOTTLE
TOPICORT desoximetasone SPRAY;TOPICAL 204141 NDA Taro Pharmaceuticals U.S.A., Inc. 51672-5281 51672-5281-6 2 BOTTLE in 1 CARTON (51672-5281-6) > 50 mL in 1 BOTTLE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SPRAY;TOPICALStrength0.25%
Approval Date:Apr 11, 2013TE:ATRLD:Yes
Patent:► SubscribePatent Expiration:Mar 24, 2018Product Flag?YSubstance Flag?Delist Request?
Patented Use:TREATMENT OF PLAQUE PSORIASIS IN PATIENTS 18 YEARS OF AGE OR OLDER
Patent:► SubscribePatent Expiration:Sep 1, 2028Product Flag?YSubstance Flag?Delist Request?
Patented Use:TREATMENT OF PLAQUE PSORIASIS IN PATIENTS 18 YEARS OF AGE OR OLDER
Patent:► SubscribePatent Expiration:May 26, 2026Product Flag?YSubstance Flag?Delist Request?
Patented Use:TREATMENT OF PLAQUE PSORIASIS IN PATIENTS 18 YEARS OF AGE OR OLDER


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Boehringer Ingelheim
AstraZeneca
Cerilliant
Daiichi Sankyo
Mallinckrodt
Deloitte
Healthtrust
US Army
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot